SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (40)7/26/1999 11:23:00 PM
From: scaram(o)uche  Read Replies (1) of 427
 
MEDI.... short 12.9K shares on 9/30 (at split-adjusted $32.40/share), covered by 3/31/99.

Heh, heh, heh.

I have long believed that there are collaborating funds out there, shorting biotechs. I never expected to run across one that was so damn blind to what they are doing.

Like Franklin Templeton, Prudent Bear, and Jim Cramer's fund, these guys had to write a "sorry about our dismal performance" letter to their investors. Why do the investors continue to assume that the fund managers know their business? Why are these clowns out willy-nilly shorting biotechs at a point where the sector has been beaten on to absurdity?

(a) no brains
(b) no brains
(c) no brains, or
(d) no brains

(multiple choice)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext